Company Management

MT-act

Biotechnology Research Montpellier, Hérault, Fr 7 employees

Employees: 7
Contacts: 2
Emails: 2

mt-act.com LinkedIn

MT-act Overview

Headquarters: Montpellier, Hérault, Fr
Website: mt-act.com
Industry: Biotechnology Research
Employees: 7
Founded: 2019
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Drug development Microtubules Tubulin code Preclinical Drug screening first-in-class drug discovery

About MT-act

MT-act is a CNRS spin-off. #techtransfer We develop class compounds to treat human pathologies that share a common molecular defect; dysfunction of the skeleton of the cells called microtubules - abbreviated MT. Stiffening of the skeleton of our cells is a central disease driver. That is why we act on them. We developed a technology platform to charter an entirely neglected pharmaceutical space. MT-act prioritizes indications based on scientific evidence, proven unmet medical needs and where the roadmap to patients is feasible and desired.

MT-act Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

MT-act Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jérémy Olive	Technicien Polyvalent - Biochimie	Pignan, Occitanie, France	View
Siem Van Der Laan	CEO / Founder Mt-act	Greater Montpellier Metropolitan Area, France	View
Khaled Hached	COO / Founder Mt-act	France	Email
Guillaume Marcellin	Project Manager Research and Development	Montpellier, Occitanie, France	Email